Yanyan Qiu

Fujian Medical University — China

Neuroscience · Life Sciences

34h-index2.7kcitations112works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(14), MicroRNA in disease regulation(11), Lymphoma Diagnosis and Treatment(8), Neuroscience and Neuropharmacology Research(7), Electrochemical sensors and biosensors(6)

Publications112 total

A rare case of variant acute promyelocytic leukemia with FIP1L1-RARA fusion gene: case report and literature review
Leukemia Research Reports·2025Open Access
Development and internal validation of a lymphoma-specific nomogram for predicting venous thromboembolism: a retrospective cohort of 790 patients
BMC Cancer·2025Open Access
Emergency online teaching during COVID-19 pandemic versus conventional offline methods in morphology experiment: An observational comparative study
Medicine·2025Open Access
Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?
Annals of Hematology·2025Open Access
Next-generation sequencing of circulating tumor DNA in cerebrospinal fluid for detecting gene mutations in central nervous system lymphoma patients
Therapeutic Advances in Hematology·2025· 2 citedOpen Access
Neurosyphilis Presenting as Sleep Disorder and Muscle Soreness Complicated With HIV Infection: A Case Report
Case Reports in Infectious Diseases·2025Open Access
Chinese advances in understanding and managing genitourinary tract infections caused by Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma urealyticum
Archives of Microbiology·2024· 11 cited
Deciphering the impact of MreB on the morphology and pathogenicity of the aquatic pathogen Spiroplasma eriocheiris
Biology Direct·2024· 5 citedOpen Access
Understanding the Dynamics of Political Economy in Relation to Energy Transition for G7 Economies
Politická ekonomie·2024· 3 citedOpen Access
Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era
BMC Cancer·2024· 2 citedOpen Access
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors
Journal of the National Cancer Center·2023· 3 citedOpen Access
The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors
Blood·2023Open Access
Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from central nervous system lymphomas patients using next generation sequencing
Research Square (Research Square)·2023Open Access
Hypofractionated Radiotherapy for Refractory or Relapsed Aggressive B-cell Lymphoma in the Rituximab Era
Research Square (Research Square)·2023Open Access
Allosteric probe-modified liposome loading bufalin-fluorouracil complex for targeted colorectal cancer therapy*
Oncology and Translational Medicine·2022· 1 citedOpen Access
Health Risk Assessment and Projection of Municipal Solid Waste Disposal in China
ISEE Conference Abstracts·2022Open Access
SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy
Molecular Psychiatry·2022· 23 cited
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
Frontiers in Aging Neuroscience·2022· 8 citedOpen Access
SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas
Frontiers in Oncology·2021· 6 citedOpen Access
Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer
Cancer Management and Research·2021· 8 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Peihao Yin(19), Ke Xu(12), Zeting Yuan(9), Shiyun Ai(8), Ruixia Han(7), Yueping Zhan(6), Jun‐Xu Li(6), Xin Liang(5), Yanan Zhang(5), Guohua Fan(4), Yijun Cao(4), Huanshun Yin(4), Tiantian Tang(4), Qingfeng Tang(4), Jianhua Xu(3), David A. Thorn(3), Vanminh Le(3), Song-Jiao Hu(3), Jianhua Xu(3), Wei Li(3)